Pharmaceutical

Otsuka and ShapeTX to develop gene therapies for eye diseases

Otsuka Pharmaceutical has entered a partnership with ShapeTX for the development of gene therapies to treat ocular diseases.

Sep 9, 2023 - 20:00
Otsuka and ShapeTX to develop gene therapies for eye diseases
Otsuka Pharmaceutical has entered a partnership with ShapeTX for the development of gene therapies to treat ocular diseases.
Read the original article

Tags:

Previous Article

Record number of respiratory syncytial virus (RSV) designations awarded in 2022

Next Article

NICE recommends Lilly’s tirzepatide to treat T2D

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Q&A: BARDA wants to back tech that can combat multiple infections, says director

Q&A: BARDA wants to back tech that can combat multiple ...

Apr 7, 2024

Pfizer boasts over 30% increase in Q3 revenues against previous year

Pfizer boasts over 30% increase in Q3 revenues against ...

Nov 1, 2024

Biotech funding optimism rises as 44% predict recovery in 2024

Biotech funding optimism rises as 44% predict recovery ...

Mar 1, 2024